IDO, a rate-limiting enzyme in tryptophan catabolism, is highly expressed in MDSCs isolated from fresh breast cancer tissues and is associated with tumor-induced immunosuppression by suppressing T cell function [38, 39]. This evidence concerns the gene IDO1 and neoplasm.